Howard Margolese, MD, MSc
Primary Axis:
Mental Illness and Addiction
Email:
Email contact form Research Focus:
Research interests include: treatment of schizophrenia and substance abuse (dual diagnosis); tardive dyskinesia and diabetes in schizophrenia; movement disorders and suicidality in schizophrenia; anticonvulsant medication as adjunctive therapy in refractory psychosis; treatment of Gilles de la Tourette Syndrome; and adverse effects of psychotropic medications.Psychopharmacology, antipsychotics, drug-induced extrapyramidal symptoms, tardive dyskinesia, akathisia, Parkinsonism, schizophrenia, Gilles de la Tourette syndrome, adverse effects, dual diagnosis, substance abuse, substance dependence
Keywords:
Psychopharmacology, antipsychotics, drug-induced extrapyramidal symptoms, tardive dyskinesia, akathisia, Parkinsonism, schizophrenia, Gilles de la Tourette syndrome, adverse effects, dual diagnosis, substance abuse, substance dependence
Location:
Royal Victoria Hospital Publications:
Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use. Schizophrenia Research 2006; 83:65-75.
Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R, Annable L. Tardive Dyskinesia in the Era of Typical an Atypical Antipsychotics (Part 2): Incidence and management strategies in patients with schizophrenia. Canadian Journal of Psychiatry 2005; 50: 703-714.
Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophrenia Research 2005; 76: 247-265.
